Which feature best distinguishes typical antipsychotics from atypical antipsychotics in terms of their neurochemical receptor profile?

Explanation

## Neurochemical Distinction Between Typical and Atypical Antipsychotics ### Key Receptor Profile Differences **Key Point:** The feature that best **distinguishes typical antipsychotics** from atypical antipsychotics is their **high affinity for D2 dopamine receptors with minimal serotonin 5-HT2A antagonism** (Option A). ### Mechanistic Basis The question asks what distinguishes **typical** antipsychotics — the answer must describe the profile unique to typicals, not atypicals. **Typical antipsychotics** (e.g., haloperidol, chlorpromazine, fluphenazine): - **High, sustained D2 receptor affinity** — tight binding with slow dissociation - **Minimal to absent 5-HT2A antagonism** — this is the defining absence that separates them from atypicals - Sustained nigrostriatal dopamine blockade → **high EPS risk (20–30%)** and **tardive dyskinesia** **Atypical antipsychotics** (e.g., clozapine, risperidone, olanzapine, quetiapine): - **Potent 5-HT2A antagonism** often exceeding D2 affinity (5-HT2A:D2 ratio > 1) - Rapid D2 dissociation (the "fast-off" hypothesis by Kapur & Seeman) - Reduced EPS due to serotonin-mediated counterbalancing of dopamine blockade in motor pathways ### Why Option B is Incorrect for This Question Option B describes the profile of **atypical** antipsychotics (rapid D2 dissociation + potent 5-HT2A antagonism). The stem asks what distinguishes **typical** antipsychotics — so Option B describes the *opposite* class and is therefore incorrect as the answer here. ### Clinical Consequence Table | Feature | Typical | Atypical | |---------|---------|----------| | D2 affinity | High, sustained | High but rapidly dissociating | | 5-HT2A antagonism | **Minimal/absent** | Potent (often > D2 affinity) | | EPS risk | High (20–30%) | Low (< 5%) | | Tardive dyskinesia | High (cumulative) | Lower | | Metabolic effects | Minimal | Moderate to high | **High-Yield:** The **absence of significant 5-HT2A antagonism** combined with **high sustained D2 blockade** is the hallmark neurochemical profile of typical antipsychotics (KD Tripathi 8e, Ch 11). **Clinical Pearl:** The 5-HT2A:D2 affinity ratio > 1 defines atypicals; typicals have this ratio < 1, explaining their higher motor side-effect burden. [cite:KD Tripathi 8e Ch 11; Stahl's Essential Psychopharmacology 4e]